About UsUnderstanding AMLInterviewsGlobal NetworkGet InvolvedStoriesResources

Should COVID-19 vaccination be postponed after AML therapy?

Sabine Haggenburg

January 6, 2022

During the 63rd ASH Annual Meeting and Exposition, Know AML spoke with Sabine Haggenburg, Amsterdam UMC, Amsterdam, NL. We asked, Should COVID-19 vaccination be postponed after AML therapy?

Haggenburg begins by discussing COVID-19 risks to AML patients, and the responses to vaccinations that have been observed so far. However, she highlights that vaccination does not protect patients taking hypomethylating agents (HMAs), such as azacitidine and decitabine.